FGF2 and liver cancer: The MCF2L-AS1-miR-33a-5p-FGF2 axis was likely to be implicated in the pathological processes of liver cancer, and MCF2L-AS1 possibly functioned as a potential biomarker for the early screening and diagnosis of cancer.